Markets
Is OncoCyte Corporation (NASDAQ:OCX) Worth A Bite? OCX 200 SMA stands at 57.36%
OncoCyte Corporation (NASDAQ:OCX) Relative Strength Index (RSI) is 63.35, with weekly volatility at 8.17% and ATR at 0.36. The OCX stock’s 52-week price range has